Jinghua Pharmaceutical Group Co., Ltd.
SHZ: 002349.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jian Cheng
- Employees
- 1,493
- Headquarters
- Nantong, China
- IPO year
- 2010
- Market cap
- CN¥6.2B
- Website
- https://www.jinghuapharm.com
Loading 002349…
Loading profile data…Frequently asked questions about 002349
What does Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) do?
Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmace...
Where does 002349.SZ trade?
Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002349.SZ in?
Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jinghua Pharmaceutical Group Co., Ltd.?
Jian Cheng is the chief executive officer of Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ).
Where is Jinghua Pharmaceutical Group Co., Ltd. headquartered?
Jinghua Pharmaceutical Group Co., Ltd. is headquartered in China.
Does 002349.SZ pay a dividend?
Yes — Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) paid a trailing twelve-month dividend of CNY 0.08 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002349.SZ go public?
Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) completed its initial public offering in 2010.